Daniel Haber
MD
Director of Massachusetts General Hospital Cancer Center
👥Biography 个人简介
Daniel Haber has pioneered the molecular characterization of circulating tumor cells, demonstrating that CTC genotyping can detect drug resistance mutations months before radiographic progression. His single-CTC RNA sequencing studies have revealed transcriptional heterogeneity among CTCs that predicts metastatic organotropism. He leads clinical studies using serial CTC analysis to guide adaptive therapy in non-small cell lung cancer and breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Daniel Haber 的研究动态
Follow Daniel Haber's research updates
留下邮箱，当我们发布与 Daniel Haber（Massachusetts General Hospital / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment